SCHEMBL29047

SCHEMBL29047

CCCCCCCCCC=C(C#N)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.58
PPARG P37231 8/20 0.44
PPARA Q07869 3/20 0.44
TRPA1 O75762 1/20 0.44
FBP1 P09467 1/20 0.44
TERT O14746 3/20 0.43
MAPT P10636 2/20 0.43
BLM P54132 2/20 0.43
HSD17B10 Q99714 2/20 0.43
FABP4 P15090 2/20 0.43
GMNN O75496 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744949 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL142755 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL154904 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL423102 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL1602959 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL3149613 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL1274680 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL973729 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL7568098 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL9361054 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9752049-B2 Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same UT-BATTELLE, LLC (US) 2017-09-05 US claimed
US-20150232690-A1 OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME UT-BATTELLE, LLC (US) 2015-08-20 US claimed
US-20100144895-A1 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-06-10 US claimed
US-7687053-B2 Forming block BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-03-30 US claimed
EP-1425319-B1 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS BOSTON SCIENT LTD (BB) 2007-09-26 EP claimed
EP-1360257-B1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS LOCTITE R & D LTD (IE) 2007-07-25 EP claimed
US-6977278-B1 Cyanoacrylate compositions curable to flexible polymeric materials LOCTITE (R&D) LTD. (IE) 2005-12-20 US claimed
EP-1425319-A1 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS Boston Scientific Limited (BB) 2004-06-09 EP claimed
WO-2004024467-A2 SURFACE-MOUNTING SYSTEM LOCTITE (R & D) LIMITED (IE) 2004-03-25 WO claimed
WO-2003016364-A1 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS SCIMED LIFE SYSTEMS, INC. (US) 2003-02-27 WO claimed
US-20030039696-A1 Forming block STRYKER EUROPEAN HOLDINGS III, LLC 2003-02-27 US claimed
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BOSTIK SA (FR) 2025-10-02 US disclosed
EP-4532465-A1 BIOBASED CYANOACRYLATE COMPOUND Bostik SA (FR) 2025-04-09 EP disclosed
WO-2023232948-A1 BIOBASED CYANOACRYLATE COMPOUND BOSTIK SA (FR) 2023-12-07 WO disclosed
EP-4286369-A1 BIOBASED CYANOACRYLATE COMPOUND Bostik SA (FR) 2023-12-06 EP disclosed
WO-2003016364-A1 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS SCIMED LIFE SYSTEMS, INC. (US) 2003-02-27 WO disclosed
US-20030032735-A1 Solid cyanoacrylate adhesive composition and method for its use CHEMENCE, INC. 2003-02-13 US disclosed
WO-2003002679-A1 SOLID DYANOACRYLATE ADHESIVE COMPOSITION AND METHOD FOR ITS USE CHEMENCE, INC. (US) 2003-01-09 WO disclosed
US-5039753-A Polymers comprising betadiketone groups and polymerizable compositions containing said polymers LOCTITE (IRELAND) LTD (IE) 1991-08-13 US disclosed
EP-0313387-A2 Polymers comprising betadiketone groups and polymerizable compositions containing said polymers LOCTITE (IRELAND) Ltd. (IE) 1989-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BAP1, CBR1, CBR3 EP300 2135/4885PPARG 4869/4885PPARA 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.